US20080020430A1 - Enzymatic Process for Preparing Aminoacyl Esters of Monosaccharides - Google Patents
Enzymatic Process for Preparing Aminoacyl Esters of Monosaccharides Download PDFInfo
- Publication number
- US20080020430A1 US20080020430A1 US10/582,690 US58269003A US2008020430A1 US 20080020430 A1 US20080020430 A1 US 20080020430A1 US 58269003 A US58269003 A US 58269003A US 2008020430 A1 US2008020430 A1 US 2008020430A1
- Authority
- US
- United States
- Prior art keywords
- reaction
- amino acid
- monosaccharides
- group
- lipase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000002772 monosaccharides Chemical class 0.000 title claims abstract description 29
- 230000002255 enzymatic effect Effects 0.000 title claims description 7
- 125000000266 alpha-aminoacyl group Chemical group 0.000 title abstract description 13
- 238000004519 manufacturing process Methods 0.000 title description 4
- 108090001060 Lipase Proteins 0.000 claims abstract description 28
- 102000004882 Lipase Human genes 0.000 claims abstract description 28
- 239000004367 Lipase Substances 0.000 claims abstract description 28
- 235000019421 lipase Nutrition 0.000 claims abstract description 28
- 150000001413 amino acids Chemical class 0.000 claims abstract description 27
- 239000012454 non-polar solvent Substances 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 32
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 30
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 27
- 229940024606 amino acid Drugs 0.000 claims description 27
- 235000001014 amino acid Nutrition 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 22
- 108090000790 Enzymes Proteins 0.000 claims description 19
- 102000004190 Enzymes Human genes 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- -1 aminoacyl ester Chemical class 0.000 claims description 17
- 235000000346 sugar Nutrition 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 15
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 13
- 210000000496 pancreas Anatomy 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 235000019454 L-leucine Nutrition 0.000 claims description 7
- 239000004395 L-leucine Substances 0.000 claims description 7
- 229960003136 leucine Drugs 0.000 claims description 7
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 claims description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 6
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 6
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
- 229960003767 alanine Drugs 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims description 3
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims description 3
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 3
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 3
- 229930064664 L-arginine Natural products 0.000 claims description 3
- 235000014852 L-arginine Nutrition 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- 229930182844 L-isoleucine Natural products 0.000 claims description 3
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 claims description 3
- 241000589540 Pseudomonas fluorescens Species 0.000 claims description 3
- 241000235403 Rhizomucor miehei Species 0.000 claims description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- 241000209140 Triticum Species 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 241000179532 [Candida] cylindracea Species 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 3
- 229960005261 aspartic acid Drugs 0.000 claims description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 229960002989 glutamic acid Drugs 0.000 claims description 3
- 229960002449 glycine Drugs 0.000 claims description 3
- 229960002885 histidine Drugs 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-dimethylbenzene Natural products CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 229960001153 serine Drugs 0.000 claims description 3
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 3
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims description 3
- 229960002898 threonine Drugs 0.000 claims description 3
- 229960004441 tyrosine Drugs 0.000 claims description 3
- 229960004295 valine Drugs 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 230000001404 mediated effect Effects 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 229940088598 enzyme Drugs 0.000 description 17
- 239000011541 reaction mixture Substances 0.000 description 14
- 239000002808 molecular sieve Substances 0.000 description 12
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 12
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-Phenylalanine Natural products OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 7
- 238000005886 esterification reaction Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 238000004448 titration Methods 0.000 description 7
- 230000032050 esterification Effects 0.000 description 6
- 239000008103 glucose Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229960005190 phenylalanine Drugs 0.000 description 4
- 108010048733 Lipozyme Proteins 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 3
- 239000012610 weak anion exchange resin Substances 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 241000580812 Hasegawazyma lactosa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 244000070804 Neurospora sitophila Species 0.000 description 2
- 235000000376 Neurospora sitophila Nutrition 0.000 description 2
- 108090000787 Subtilisin Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- POYBEXULXWCCLI-LBPRGKRZSA-N 2-chloroethyl (2s)-2-acetamido-3-phenylpropanoate Chemical compound ClCCOC(=O)[C@@H](NC(=O)C)CC1=CC=CC=C1 POYBEXULXWCCLI-LBPRGKRZSA-N 0.000 description 1
- 238000005084 2D-nuclear magnetic resonance Methods 0.000 description 1
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 102000053002 Lipase-like Human genes 0.000 description 1
- 108700039553 Lipase-like Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000235402 Rhizomucor Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- GSYSFVSGPABNNL-UHFFFAOYSA-N methyl 2-dimethoxyphosphoryl-2-(phenylmethoxycarbonylamino)acetate Chemical group COC(=O)C(P(=O)(OC)OC)NC(=O)OCC1=CC=CC=C1 GSYSFVSGPABNNL-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 108091016642 steapsin Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Definitions
- the present invention provides an improved enzymatic process for the preparation of aminoacyl esters of monosaccharides.
- the present invention particularly relates to lipase mediated synthesis of aminoacyl esters of monosaccharides.
- the present invention further relates to preparation of aminoacyl esters of monosaccharides from unprotected amino acids and monosaccharides in non-polar solvents using lipases.
- Aminoacyl esters of sugars are used as detergents, sweetening agents, as microcapsules in pharmaceutical preparations, in delivery of biological active agents, as antiviral nucleoside amino acid esters, as emulsions and as antibiotics.
- Regioselective acylation of carbohydrates is a challenging objective, quite difficult to achieve because of several hydroxyl groups in these molecules (Haines, A. H. Advances in Carbohydrate Chemistry and Biochemistry, 1976, 33, 11). Selective synthesis of these compounds using chemical reagents do not lead to products arising out of reactions at specific positions of the sugar molecules employed. Few regioselective transformations of carbohydrates have been carried out recently using enzymes (Wong, C. H. and Whitesides, G. M. Enzymes in organic synthesis, Elsevier Science, Oxford, 1994). Of these enzymatic synthesis of aminoacyl esters of sugars are very scanty.
- the main object of the present invention is to provide an improved enzymatic process for preparing amino acyl esters of sugars which obviates the drawbacks as detailed above.
- Another object of the present invention is to use underivatised amino acids without protecting amino groups or activating carboxyl groups.
- Still another object of the present invention is to use underivatised monosaccharides as the sugar molecule
- Yet another object of the present invention is to provide a process for preparing amino acyl esters of sugars with large conversion.
- Yet another object of the present invention is to employ readily available commercial lipases like porcine pancreas lipase and Rhizomucor miehei lipase.
- Yet another object of the present invention is to use lesser amounts of enzyme for achieving better conversions than what has been described in the above mentioned methods.
- Still another object of the present invention is to use low boiling solvents in the temperature range 40° C.-80° C.
- Yet another object of the present invention is to obtain aminoacyl esters of monosaccharides where a mixture of three monoesters, 6-O-aminoacyl, 3-O-aminoacyl and 2-O-aminoacyl esters are produced by the enzymatic reaction.
- Novelty of the present invention is that it uses underivatised amino acids where no amino group was protected and no carboxyl group was activated.
- An experimental set up was employed which facilitates use of larger concentrations of substrates and lesser amounts of enzymes.
- Commercially and readily available lipases can be employed.
- the procedure developed can be employed in the preparation of any aminoacyl sugar ester at even large-scale levels.
- the present invention provides an improved enzymatic process for the preparation of an aminoacyl ester of a monosaccharide which comprises reacting an underivatised amino acid with a sugar in the presence of an enzyme and a non-polar solvent to produce an aminoacyl ester of a monosaccharide and recovering the product.
- the amino acid is without any N-protection and carboxyl activation.
- the amino acid is selected from the group consisting of glycine, L-alanine, L-valine, L-leucine, L-isoleucine, L-phenylalanine, L-tyrosine, L-histidine, L-tryptophan, L-lysine, L-aspartic acid, L-glutamic acid, L-arginine, L-serine, L-threonine and their corresponding D, L-mixtures.
- the underivatised sugar is a monosaccharide selected from the group consisting of D-glucose, D-fructose, D-galactose, D-mannose, D-arabinose, ribose and deoxyribose.
- the enzyme is a lipase selected from the group consisting of lipases obtained from porcine pancreas, Rhizomucor miehei, Candida cylindracea, Pseudomonas fluorescens and wheat germ.
- the solvent is a low boiling solvent having a boiling range 40° C.-80° C. and selected from the group consisting of dichloromethane, diisopropyl ether, chloroform, hexane, pentane, petroleum ether (60° C.-80° C. fraction), pyridine, dimethyl formamide, dimethyl sulfoxide, benzene and any mixture thereof
- reaction is carried out for a period in the range of 2-5 days.
- the reaction is carried out at a temperature in the range of 40° C.-80° C.
- the present invention provides an improved enzymatic process for the preparation of an aminoacyl ester of a monosaccharide.
- the process comprises reacting an underivatised amino acid with a sugar in the presence of an enzyme and a non polar solvent preferably for a period of 2-5 days and at a temperature in the range 40° C.-80° C.
- the aminoacyl ester of a monosaccharide obtained are then recovered by conventional methods which are known in the art.
- amino acids employed are underivatised free ones without any N-protection and carboxyl activation.
- amino acids include glycine, L-alanine, L-valine, L-leucine, L-isoleucine, L-phenylalanine, L-tyrosine, L-histidine, L-tryptophan, L-lysine, L-aspartic acid, L-glutamic acid, L-arginine, L-serine, L-threonine and their corresponding D, L-mixtures.
- the underivatised sugar used for esterification is a monosaccharide including D-glucose, D-fructose, D-galactose, D-mannose, D-arabinose, ribose and deoxyribose.
- the enzyme used can be a commercially available lipase from porcine pancreas, Rhizomucor miehei, Candida cylindracea, Pseudomonas fluorescens and wheat germ.
- the solvent employed is a low boiling solvent having a boiling range 40° C.-80° C. such as dichloromethane, diisopropyl ether, chloroform, hexane, pentane, petroleum ether (60° C.-80° C. fraction), pyridine, dimethyl formamide, dimethyl sulfoxide, benzene and any mixture thereof.
- Porcine pancreas lipase a Type II (Steapsin) was purchased from M/S Sigma Chemical. Co. Mo, USA.
- Lipozyme-IM20 a Rhizomucor meihei lipase, immobilized on a weak anion exchange resin, was obtained from Novo, Denmark. Esterification activities of porcine pancreas lipase and Lipozyme-IM20 were determined by an esterification procedure (Kiran, K. R., Hari Krishna, S., Suresh Babu, C. V., Karanth, N. G. and Divakar, S. Unpublished data, 1999).
- Activity assay measures butyric acid reacted after the enzyme was incubated with a mixture of butanol (0.32 M) and butyric acid (0.16 M) in n-heptane for a specified period of time. Protein was estimated by Lowry's method (Lowry, O. H., Roseborough, N. J., Farr, N. L. and Randall, R. J. J. Biol. Chem. 193, 265-275, 1951). Esterification activities of porcine pancreas lipase, and Lipozyme-IM20 were 0.06 and 0.46 ⁇ moles/min/mg of the enzyme respectively.
- Underivatised amino acid (0.001-0.01 mol) was taken in a flat bottomed two necked flask along with 50-500 ml of the solvent or a solvent mixture in presence of 0.1-2.0 g porcine pancreas lipase and refluxed for a period of 2-5 days in the temperature range of 40° C.-80° C.
- the reaction mixture was then added to 20-100 mL of water, stirred and filtered to remove the lipase.
- the filtrate was evaporated over a water bath to get a mixture of unreacted monosaccharides, unreacted amino acid and the aminoacyl esters of monosaccharides.
- Percentage of esterification was determined by a back titration procedure whereby a known weight of the sample was treated with a known excess of 0.05 N KOH and the excess unreacted KOH was titrated against 0.1 N oxalic acid. From the titre value corresponding to the free acid the amount of free acid was determined. From the known weight of the amino acid employed the extent of ester formed was determined.
- the aminoacyl ester of monosaccharides was characterized by recording one-dimensional 1 H and 13 C NMR and two-dimensional NMR spectra on a Brüker DRX-400 and 500 NMR instruments operating at 20° C. Samples were dissolved in DMSO-d 6 and D 2 O and the signals were referenced to DSS.
- the reaction mixture on analysis showed the formation of three monoesters and about 5% of peptides.
- reaction mixture was then added to 50 mL of water, stirred and filtered to remove the lipase.
- the filtrate was evaporated over a water bath to the get a mixture of unreacted monosaccharides, unreacted amino acid and the L-phenylalanyl glucose esters.
- the reaction by the back titration method gave a: conversion yield of 27.0% and by HPLC 36.5%.
- reaction mixture was then added to 50 mL of water, stirred and filtered to remove the lipase.
- the filtrate was evaporated over a water bath to the get a mixture of unreacted monosaccharides, unreacted amino acid and the L-leucyl glucose esters.
- the reaction by the back titration method gave a conversion yield of 75.3% and by HPLC 54.7%.
- reaction mixture was then added to 50 mL of water, stirred and filtered to remove the lipase.
- the filtrate was evaporated over a water bath to the get a mixture of unreacted monosaccharides, unreacted amino acid and the L-leucyl glucose esters.
- the reaction by the back titration method gave a conversion yield of 84.4%.
Abstract
The present invention particularly relates to lipase mediated synthesis of aminoacyl esters of monosaccarides from unprotected amino acids and monosaccharides in non-polar solvents using lipases.
Description
- The present invention provides an improved enzymatic process for the preparation of aminoacyl esters of monosaccharides. The present invention particularly relates to lipase mediated synthesis of aminoacyl esters of monosaccharides. The present invention further relates to preparation of aminoacyl esters of monosaccharides from unprotected amino acids and monosaccharides in non-polar solvents using lipases.
- Aminoacyl esters of sugars are used as detergents, sweetening agents, as microcapsules in pharmaceutical preparations, in delivery of biological active agents, as antiviral nucleoside amino acid esters, as emulsions and as antibiotics. Regioselective acylation of carbohydrates is a challenging objective, quite difficult to achieve because of several hydroxyl groups in these molecules (Haines, A. H. Advances in Carbohydrate Chemistry and Biochemistry, 1976, 33, 11). Selective synthesis of these compounds using chemical reagents do not lead to products arising out of reactions at specific positions of the sugar molecules employed. Few regioselective transformations of carbohydrates have been carried out recently using enzymes (Wong, C. H. and Whitesides, G. M. Enzymes in organic synthesis, Elsevier Science, Oxford, 1994). Of these enzymatic synthesis of aminoacyl esters of sugars are very scanty.
- Reference is made to Suzuki, Y., Shimizu, T., Takeda, H. And Kanda, K. Jpn Kokai Tokkyo Koho JP. 03216194 A2 24 Sep. 1991 wherein sugar esters of amino acids have been synthesised using enzymes from Neurospora sitophila and Rhodotorula lactosa.
- Reference is made to Riva, S., Chopineau, J., Kieboom, A. P. G. and Klibanov, A. M. J. Amer. Chem. Soc., 110, 584-589, 1988, wherein 15 mmol of monosaccharides and 6 mmol of N-acetyl-L-phenylalanine chloroethyl ester dissolved in 30 mL of anhydrous dimethyl formamide containing 0.6 g subtilisin was shaken at 45° C. and 250 rpm for 16 h.
- Reference is made to Oh-Jin Park, Gyo-Jong Jeon and Ji-Won Yang, Enzyme and Microbial Technology, 25, 455-462, 1999, wherein 1.03 g sucrose and 4.16 g of t-Boc-L-PheOTFE dissolved in 50 ml of pyridine at 45° C. in 250 ml round bottom flask containing 5 g of enzyme Optimase M-440 was shaken at 250 rpm for 8 days.
- Reference is also made to Oh-Jin Park, Gyo-Jong Jeon and Ji-Won Yang, Biotech Letters, 18, 473-478, 1996 wherein a mixture of sugar and t-Boc-L-Phe-TFE sealed in a glass vial containg Optimase M-440 was shaken at 250 rpm at 45° C.
- Reference is made to Yu Mitin, V., Kashparov, I. A., Kuhl, P. And Scheller, D. Bioorg. Khim., 25(4), 243-246, 1999, wherein sorbitol was esterified with N-benzyloxyvarbonyl alanine using papain.
- Major drawbacks of the above mentioned enzymatic methods are:
- 1. The reactions were conducted at shake-flask levels using lesser quantities of the substrates and larger concentrations of the enzymes.
- 2. Several enzymes like Optimase M-440, subtilisin and from Neurospora sitophila and Rhodotorula lactosa were employed which are not readily available commercially.
- 3. Larger periods of incubation up to 8 days were employed.
- 4. The amino acids used were all derivatised to be protected at the amino positions. N-t-BOC and N-benzyloxycarbonyl groups were the protecting groups introduced.
- 5. In some cases the amino groups were also activated by derivatising at the carboxyl positions to undergo facile reaction. Mostly trifluoroethyl esters of amino acids were prepared before subjecting them to transesterification reaction with monosaccharides.
- The main object of the present invention is to provide an improved enzymatic process for preparing amino acyl esters of sugars which obviates the drawbacks as detailed above.
- Another object of the present invention is to use underivatised amino acids without protecting amino groups or activating carboxyl groups.
- Still another object of the present invention is to use underivatised monosaccharides as the sugar molecule Yet another object of the present invention is to provide a process for preparing amino acyl esters of sugars with large conversion.
- It is another object of the invention to provide a process for preparing amino acyl esters of sugars with continuous removal of water thereby maintaining very low water activity essential for enzyme catalysed esterification reactions.
- Yet another object of the present invention is to employ readily available commercial lipases like porcine pancreas lipase and Rhizomucor miehei lipase.
- Yet another object of the present invention is to use lesser amounts of enzyme for achieving better conversions than what has been described in the above mentioned methods.
- Still another object of the present invention is to use low boiling solvents in the temperature range 40° C.-80° C.
- Yet another object of the present invention is to obtain aminoacyl esters of monosaccharides where a mixture of three monoesters, 6-O-aminoacyl, 3-O-aminoacyl and 2-O-aminoacyl esters are produced by the enzymatic reaction.
- Novelty of the present invention is that it uses underivatised amino acids where no amino group was protected and no carboxyl group was activated. An experimental set up was employed which facilitates use of larger concentrations of substrates and lesser amounts of enzymes. Commercially and readily available lipases can be employed. The procedure developed can be employed in the preparation of any aminoacyl sugar ester at even large-scale levels.
- Accordingly, the present invention provides an improved enzymatic process for the preparation of an aminoacyl ester of a monosaccharide which comprises reacting an underivatised amino acid with a sugar in the presence of an enzyme and a non-polar solvent to produce an aminoacyl ester of a monosaccharide and recovering the product.
- In one embodiment of the invention, the amino acid is without any N-protection and carboxyl activation.
- In another embodiment of the invention, the amino acid is selected from the group consisting of glycine, L-alanine, L-valine, L-leucine, L-isoleucine, L-phenylalanine, L-tyrosine, L-histidine, L-tryptophan, L-lysine, L-aspartic acid, L-glutamic acid, L-arginine, L-serine, L-threonine and their corresponding D, L-mixtures.
- In another embodiment of the invention, the underivatised sugar is a monosaccharide selected from the group consisting of D-glucose, D-fructose, D-galactose, D-mannose, D-arabinose, ribose and deoxyribose.
- In another embodiment of the invention, the enzyme is a lipase selected from the group consisting of lipases obtained from porcine pancreas, Rhizomucor miehei, Candida cylindracea, Pseudomonas fluorescens and wheat germ.
- In another embodiment of the invention, the solvent is a low boiling solvent having a boiling range 40° C.-80° C. and selected from the group consisting of dichloromethane, diisopropyl ether, chloroform, hexane, pentane, petroleum ether (60° C.-80° C. fraction), pyridine, dimethyl formamide, dimethyl sulfoxide, benzene and any mixture thereof
- In another embodiment of the present invention, the reaction is carried out for a period in the range of 2-5 days.
- In yet another embodiment of the invention, the reaction is carried out at a temperature in the range of 40° C.-80° C.
- The present invention provides an improved enzymatic process for the preparation of an aminoacyl ester of a monosaccharide. The process comprises reacting an underivatised amino acid with a sugar in the presence of an enzyme and a non polar solvent preferably for a period of 2-5 days and at a temperature in the range 40° C.-80° C. The aminoacyl ester of a monosaccharide obtained are then recovered by conventional methods which are known in the art.
- The amino acids employed are underivatised free ones without any N-protection and carboxyl activation. Examples of such amino acids include glycine, L-alanine, L-valine, L-leucine, L-isoleucine, L-phenylalanine, L-tyrosine, L-histidine, L-tryptophan, L-lysine, L-aspartic acid, L-glutamic acid, L-arginine, L-serine, L-threonine and their corresponding D, L-mixtures.
- The underivatised sugar used for esterification is a monosaccharide including D-glucose, D-fructose, D-galactose, D-mannose, D-arabinose, ribose and deoxyribose. The enzyme used can be a commercially available lipase from porcine pancreas, Rhizomucor miehei, Candida cylindracea, Pseudomonas fluorescens and wheat germ.
- The solvent employed is a low boiling solvent having a boiling range 40° C.-80° C. such as dichloromethane, diisopropyl ether, chloroform, hexane, pentane, petroleum ether (60° C.-80° C. fraction), pyridine, dimethyl formamide, dimethyl sulfoxide, benzene and any mixture thereof.
- Porcine pancreas lipase, a Type II (Steapsin) was purchased from M/S Sigma Chemical. Co. Mo, USA. Lipozyme-IM20, a Rhizomucor meihei lipase, immobilized on a weak anion exchange resin, was obtained from Novo, Denmark. Esterification activities of porcine pancreas lipase and Lipozyme-IM20 were determined by an esterification procedure (Kiran, K. R., Hari Krishna, S., Suresh Babu, C. V., Karanth, N. G. and Divakar, S. Unpublished data, 1999). Activity assay measures butyric acid reacted after the enzyme was incubated with a mixture of butanol (0.32 M) and butyric acid (0.16 M) in n-heptane for a specified period of time. Protein was estimated by Lowry's method (Lowry, O. H., Roseborough, N. J., Farr, N. L. and Randall, R. J. J. Biol. Chem. 193, 265-275, 1951). Esterification activities of porcine pancreas lipase, and Lipozyme-IM20 were 0.06 and 0.46 μmoles/min/mg of the enzyme respectively.
- Underivatised amino acid (0.001-0.01 mol) was taken in a flat bottomed two necked flask along with 50-500 ml of the solvent or a solvent mixture in presence of 0.1-2.0 g porcine pancreas lipase and refluxed for a period of 2-5 days in the temperature range of 40° C.-80° C. The reaction mixture was then added to 20-100 mL of water, stirred and filtered to remove the lipase. The filtrate was evaporated over a water bath to get a mixture of unreacted monosaccharides, unreacted amino acid and the aminoacyl esters of monosaccharides.
- Percentage of esterification was determined by a back titration procedure whereby a known weight of the sample was treated with a known excess of 0.05 N KOH and the excess unreacted KOH was titrated against 0.1 N oxalic acid. From the titre value corresponding to the free acid the amount of free acid was determined. From the known weight of the amino acid employed the extent of ester formed was determined. The aminoacyl ester of monosaccharides was characterized by recording one-dimensional 1H and 13C NMR and two-dimensional NMR spectra on a Brüker DRX-400 and 500 NMR instruments operating at 20° C. Samples were dissolved in DMSO-d6 and D2O and the signals were referenced to DSS.
- The reaction mixture on analysis showed the formation of three monoesters and about 5% of peptides.
- NMR data for L-Phenylalanine glucose esters:
- 6-O-Ester: 1H δppm: βCH2a-3.26; βCH2b-2.94; Aromatic H2,6-7.23; H3,5-7.29; H4-7.24; H1-4.93; H4-3.47; H5-3.64; H6a-3.72; H6b-3.45; 13C δppm: βC-36.2; Aromatic-C1-137.1; C2-127.6; C3-130.0; C4-127.8; C5-130.1; C6-127.6. C1α-101.8; C4α-71.0; C5α-78.7; C6α-64.4; C0-170.7.
- 3-O-Ester: 1H δppm: βCH2a-2.93; βCH2b-2.80; αCH-3.57; H3-3.76; H3-3.88. 13C δppm: βC-36.3: αC-53.6; Aromatic-C1-137.2; C1α-99.9; C3α-82.5; C3β-83.5; Co-170.9.
- 2-O-Ester: 1H δppm: βCH2a-2.95; βCH2b-2.82; αCH-3.13; H2-3.45. 13C δppm: αC-52.6; C1α-95.8; C2α-77.0; C2β-75.1; Co-171.4.
- NMR data for L-Leucine monosaccharides esters:
- 6-O-Ester: 1H δppm: αCH-3.05; γ-CH-1.65; δ-CH3-0.55; ε-CH3-0.50; H3-3.8; H3-3.95; H4-3.74; H6a-3.7; H6b-3.45. 13C δppm: αC-53.0; γ-C-20.9; δ-C-11.5; ε-C-14.0; Co-172.5; C3α-83.0; C3β-84.0; C4α-70.0; C6α-64.9.
- 3-O-Ester 1H δppm: γCH-2.69
- The following examples are given by way of illustration and therefore should not be construed to limit the scope of the present invention.
- A 0.025 mol of D-glucose and 0.025 mol of free L-phenylalanine was taken in 100 ml dimethyl formamide: dichloromethane mixture (1:9) in a two-necked round bottomed flask fitted with a Soxhelet apparatus filled with molecular sieves. The reaction mixture was treated with 0.09 g of Lipozyme IM-20, a Rhizomucor miehei lipase immobilized on weak anion exchange resin and refluxed at 40° C. for a period of 72 h. Continuous removal of water was achieved by condensing the solvent vapours into molecular sieves before they were drained into the flask. After the reaction, the reaction mixture was then added to 50 mL of water, stirred and filtered to remove the lipase. The filtrate was evaporated over a water bath to the get a mixture of unreacted monosaccharides, unreacted amino acid and the L-phenylalanyl glucose esters. The reaction by the back titration method gave a: conversion yield of 27.0% and by HPLC 36.5%.
- 0.001 mol of glucose and 0.001 mol of free L-phenylalanine was taken in 100 ml dimethyl formamide: dichloromethane mixture (1:9) in a two-necked round bottomed flask fitted with a Soxhelet apparatus filled with molecular sieves. The reaction mixture was treated with 0.036 g of porcine pancreas lipase and refluxed at 40° C. for a period of 72 h. Continuous removal of water was achieved by condensing the solvent vapours into molecular sieves before they were drained into the flask. After the reaction, the reaction mixture was then added to 50 mL of water, stirred and filtered to remove the lipase. The filtrate was evaporated over a water bath to the get a mixture of unreacted monosaccharides, unreacted amino acid and the L-phenylalanyl glucose esters. The reaction by the back titration method gave a conversion yield of 36.5% and by HPLC 56.5%
- 0.001 mol of glucose and 0.003 mol of free L-phenylalanine was taken in 100 ml dimethyl formamide: dichloromethane mixture (1:9) in a two-necked round bottomed flask fitted with a Soxhelet apparatus filled with molecular sieves. The reaction mixture was treated with 0.036 g, of porcine pancreas lipase and refluxed at 40° C. for a period of 72 h. Continuous removal of water was achieved by condensing the solvent vapours into molecular sieves before they were drained into the flask. After the reaction, the reaction mixture was then added to 50 mL of water, stirred and filtered to remove the lipase. The filtrate was evaporated over a water bath to the get a mixture of unreacted monosaccharides, unreacted amino acid and the L-phenylalanyl glucose esters. The reaction by the back titration method gave a conversion yield of 57.0% and by HPLC 52.0%.
- 0.001 mol of glucose and 0.001 mol of free L-leucine was taken in 100 ml dimethyl formamide: dichloromethane mixture (1:9) in a two-necked round bottomed flask fitted with a Soxhelet apparatus filled with molecular sieves. The reaction mixture was treated with 0.055 g of Lipozyme IM-20, a Rhizomucor miehei lipase immobilized on weak anion exchange resin and refluxed at 40° C. for a period of 72 h. Continuous removal of water was achieved by condensing the solvent vapours into molecular sieves before they were drained into the flask. After the reaction, the reaction mixture was then added to 50 mL of water, stirred and filtered to remove the lipase. The filtrate was evaporated over a water bath to the get a mixture of unreacted monosaccharides, unreacted amino acid and the L-leucyl glucose esters. The reaction by the back titration method gave a conversion yield of 75.3% and by HPLC 54.7%.
- 0.001 mol of glucose and 0.001 mol of free L-leucine was taken in 100 ml dimethyl formamide: dichloromethane mixture (1:9) in a two-necked round bottomed flask fitted with a Soxhelet apparatus filled with molecular sieves. The reaction mixture was treated with 0.072 g of porcine pancreas and refluxed at 40° C. for a period of 72 h. Continuous removal of water was achieved by condensing the solvent vapours into molecular sieves before they were drained into the flask. After the reaction, the reaction mixture was then added to 50 mL of water, stirred and filtered to remove the lipase. The filtrate was evaporated over a water bath to the get a mixture of unreacted monosaccharides, unreacted amino acid and the L-leucyl glucose esters. The reaction by the back titration method gave a conversion yield of 43.8% and by HPLC 68.0%.
- 0.001 mol of glucose and 0.005 mol of free L-leucine was taken in 100 ml dimethyl formamide: dichloromethane mixture (1:9) in a two-necked round bottomed flask fitted with a Soxhelet apparatus filled with molecular sieves. The reaction mixture was treated with 0.054 g of Lipozyme IM-20, a Rhizomucor miehei lipase immobilized on weak anion exachange resin and refluxed at 40° C. for a period of 72 h. Continuous removal of water was achieved by condensing the solvent vapours into molecular sieves before they were drained into the flask. After the reaction, the reaction mixture was then added to 50 mL of water, stirred and filtered to remove the lipase. The filtrate was evaporated over a water bath to the get a mixture of unreacted monosaccharides, unreacted amino acid and the L-leucyl glucose esters. The reaction by the back titration method gave a conversion yield of 84.4%.
- The main advantages of the invention are:
- 1. Employment of underivatised amino acids. Even derivatised amino acids can be employed.
- 2. Larger conversions were achieved by carrying out reactions in a specially designed experimental setup.
- 3. An experimental set up developed enabled continuous removal of water of reaction which otherwise resulted in reducing the extent of esterification due to hydrolysis.
- 4. Use of a readily available commercial lipase like porcine pancreas lipase Rhizomicor miehei lipase.
- 5. Employment of lesser amount of the enzyme for achieving better conversions.
- 6. This method does not involve any derivatisation of Monosaccharides.
- 7. Employment of low boiling solvents in the temperature range 40° C.-80° C.
- 8. This method can be employed for obtaining conversions at even large-scale levels.
Claims (9)
1. A enzymatic process for the preparation of an aminoacyl ester of a monosaccharide which comprises reacting an underivatised amino acid with a sugar in the presence of an enzyme and a non-polar solvent to produce an aminoacyl ester of a monosaccharide and recovering the product.
2. A process as claimed in claim 1 wherein the amino acid is without any N-protection and carboxyl activation.
3. A process as claimed in claim 1 wherein the amino acid is selected from the group consisting of glycine, L-alanine, L-valine, L-leucine, L-isoleucine, L-phenylalanine, L-tyrosine, L-histidine, L-tryptophan, L-lysine, L-aspartic acid, L-glutamic acid, L-arginine, L-serine, L-threonine and their corresponding D, L-mixtures.
4. A process as claimed in claim 1 wherein the underivatised sugar is a monosaccharide selected from the group consisting of D-glucose, D-fructose, D-galactose, D-mannose, D-arabinose, ribose and deoxyribose.
5. A process as claimed in claim 1 wherein the enzyme is a lipase selected from the group consisting of lipases obtained from porcine pancreas, Rhizomucor miehei, Candida cylindracea, Pseudomonas fluorescens and wheat germ.
6. A process as claimed in claim 1 wherein the solvent is a low boiling solvent having a boiling range 40° C.-80° C. and selected from the group consisting of dichloromethane, diisopropyl ether, chloroform, hexane, pentane, petroleum ether (60° C.-80° C. fraction), pyridine, dimethyl formamide, dimethyl sulfoxide, benzene and any mixture thereof.
7. A process as claimed in claim 1 wherein the the reaction is carried out for a period in the range of 2-5 days.
8. A process as claimed in claim 1 wherein the reaction is carried out at a temperature in the range of 40° C.-80° C.
9. A process as claimed in claim 1 wherein the product is separated by filtration.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2003/000466 WO2005064004A1 (en) | 2003-12-31 | 2003-12-31 | Enzymatic process for preparing aminoacyl esters of monosaccharides |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080020430A1 true US20080020430A1 (en) | 2008-01-24 |
Family
ID=34717582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/582,690 Abandoned US20080020430A1 (en) | 2003-12-31 | 2003-12-31 | Enzymatic Process for Preparing Aminoacyl Esters of Monosaccharides |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080020430A1 (en) |
EP (1) | EP1699932A1 (en) |
JP (1) | JP2007528694A (en) |
AU (1) | AU2003300722A1 (en) |
WO (1) | WO2005064004A1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03216194A (en) * | 1990-01-19 | 1991-09-24 | Asahi Chem Ind Co Ltd | Preparation of saccharide amino acid ester |
-
2003
- 2003-12-31 JP JP2005512764A patent/JP2007528694A/en active Pending
- 2003-12-31 AU AU2003300722A patent/AU2003300722A1/en not_active Abandoned
- 2003-12-31 WO PCT/IN2003/000466 patent/WO2005064004A1/en active Application Filing
- 2003-12-31 EP EP03819217A patent/EP1699932A1/en not_active Withdrawn
- 2003-12-31 US US10/582,690 patent/US20080020430A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2007528694A (en) | 2007-10-18 |
WO2005064004A1 (en) | 2005-07-14 |
EP1699932A1 (en) | 2006-09-13 |
AU2003300722A1 (en) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Valivety et al. | Chemo‐enzymatic synthesis of amino acid‐based surfactants | |
SU1630617A3 (en) | Process for preparation fructozyldisaccarides | |
Torres et al. | Part III. Direct enzymatic esterification of lactic acid with fatty acids | |
Kamiya et al. | Surfactant‐coated lipase suitable for the enzymatic resolution of menthol as a biocatalyst in organic media | |
Takaoka et al. | Inhibition of N-acetylglucosaminyl transfer enzymes: Chemical-enzymic synthesis of new five-membered acetamido azasugars | |
Li et al. | Esterification degree of fructose laurate exerted by Candida antarctica lipase B in organic solvents | |
US20100216195A1 (en) | Enzymatic Production of Sucrose-6-Ester, an Intermediate for the Manufacturing of Halo Sugars... | |
Park et al. | Protease-catalyzed synthesis of disaccharide amino acid esters in organic media | |
Murakami et al. | Enzymatic transformation of glyceroglycolipids into sn-1 and sn-2 lysoglyceroglycolipids by use of Rhizopus arrhizus lipase | |
Crout et al. | Modern Synthetic Methods 1989 | |
Fang et al. | Enzymes in organic synthesis: alteration of reversible reactions to irreversible processes | |
US20080020430A1 (en) | Enzymatic Process for Preparing Aminoacyl Esters of Monosaccharides | |
JPH104992A (en) | Solvent free production of ester compounds using enzyme | |
Vijayakumar et al. | Lipase catalyzed synthesis of L-alanyl, L-leucyl and L-phenylalanyl esters of D-glucose using unprotected amino acids | |
Baker et al. | An improved strategy for the stereoselective synthesis of glycosides using glycosidases as catalysts | |
EP1591531A1 (en) | Process for acyl-transfer enzyme reactions with acyl- coenzyme a | |
EP0220028B1 (en) | Process for producing l-aspartyl-l-phenylalanine and its diketopiperazine | |
Moravcová et al. | Enzymic Hydrolysis of Methyl 2, 3-O-Acetyl-5-Deoxy-α and β-D-Xylofuranosides-An Active-Site Model of Pig Liver Esterase | |
KR102657363B1 (en) | A synthesis method and synthesis kit for novel naringin compound having antioxidant activity and anti-inflammatory activity through chemical synthesis method | |
KR102657359B1 (en) | A novel compound having antioxidant activity and anti-inflammatory activity and a composition for antioxidant activity and anti-inflammatory according to thereof | |
JPH0416194A (en) | Production of ester mixture | |
Lohith | Enzymatic synthesis of selected amino acid esters of sugars | |
JP4644433B2 (en) | Method for producing novel D-allose fatty acid ester | |
KR20090057387A (en) | Method for producing optically active succinimide compound | |
Smallridge et al. | The Enzyme Catalysed Stereoselective Transesterification of Phenylalanine Derivatives in Supercritical Carbon Dioxide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH, IND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KENCHAIAH, LOHITH;GIRIYAPURA, REVANASIDDAPPA VIJAYAKUMAR;BALARAM, MANOHAR;AND OTHERS;REEL/FRAME:019385/0501;SIGNING DATES FROM 20070402 TO 20070413 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |